Giuseppe D.
- Country
- Italy
- Department
- Diabetes and Metabolic Diseases Center
Research Overview
- ISIS 678354-CS6 A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of Olezarsen (ISIS 678354) Administered Subcutaneously to Patients with Severe Hypertriglyceridemia
- Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Olezarsen (ISIS 678354) in Hypertriglyceridemia and Atherosclerotic Cardiovascular Disease
Data & Insights
Has run more than one trial at 23 of 145 partner sites.
Specializations
Cardiovascular Medicine
The investigator specializes in treating cardiovascular diseases with a particular focus on atherosclerosis and related conditions that affect heart health.
- Atherosclerotic cardiovascular disease management
- Preventive cardiology interventions
- Cardiovascular risk assessment
Their work encompasses comprehensive cardiovascular care and disease prevention strategies.
Metabolic Disorders
The investigator has developed expertise in treating hypertriglyceridemia and related metabolic conditions that impact cardiovascular health.
- Lipid disorder management
- Triglyceride level regulation
- Metabolic syndrome treatment
Their practice focuses on innovative approaches to managing complex metabolic conditions.
Preventive Medicine
The investigator's work extends to preventive care strategies for patients with elevated cardiovascular risk factors.
- Risk factor modification
- Preventive therapeutic strategies
- Long-term cardiovascular health maintenance
Their approach integrates preventive measures with active disease management.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.